Maxinutrition Group Holdings Ltd., GlaxoSmithKline deal

GlaxoSmithKline will acquire protein-based functional nutrition product manufacturer Maxinutrition from private equity firm Darwin Private Equity for about £162 million ($255.2 million) in cash, inclu...